221 related articles for article (PubMed ID: 36262190)
1. Drug-Loaded Acoustic Nanodroplet for Dual-Imaging Guided Highly Efficient Chemotherapy Against Nasopharyngeal Carcinoma.
Yang D; Chen Q; Zhang M; Feng G; Sun D; Lin L; Jing X
Int J Nanomedicine; 2022; 17():4879-4894. PubMed ID: 36262190
[TBL] [Abstract][Full Text] [Related]
2. Low-intensity focused ultrasound (LIFU)-activated nanodroplets as a theranostic agent for noninvasive cancer molecular imaging and drug delivery.
Liu J; Xu F; Huang J; Xu J; Liu Y; Yao Y; Ao M; Li A; Hao L; Cao Y; Hu Z; Ran H; Wang Z; Li P
Biomater Sci; 2018 Nov; 6(11):2838-2849. PubMed ID: 30229771
[TBL] [Abstract][Full Text] [Related]
3. Drug Release from Phase-Changeable Nanodroplets Triggered by Low-Intensity Focused Ultrasound.
Cao Y; Chen Y; Yu T; Guo Y; Liu F; Yao Y; Li P; Wang D; Wang Z; Chen Y; Ran H
Theranostics; 2018; 8(5):1327-1339. PubMed ID: 29507623
[No Abstract] [Full Text] [Related]
4. Phase-shift, targeted nanoparticles for ultrasound molecular imaging by low intensity focused ultrasound irradiation.
Li M; Luo H; Zhang W; He K; Chen Y; Liu J; Chen J; Wang D; Hao L; Ran H; Zheng Y; Wang Z; Li P
Int J Nanomedicine; 2018; 13():3907-3920. PubMed ID: 30013344
[TBL] [Abstract][Full Text] [Related]
5. Concurrent anti-vascular therapy and chemotherapy in solid tumors using drug-loaded acoustic nanodroplet vaporization.
Ho YJ; Yeh CK
Acta Biomater; 2017 Feb; 49():472-485. PubMed ID: 27836803
[TBL] [Abstract][Full Text] [Related]
6. Study on Contrast-Enhanced Ultrasound Imaging and Anti-Tumor Effects of Drug-Loaded Nanodroplets with Tumor Targeting and Ultrasound Sensitivity.
Li Y; Chen Y; Liu R; Duan S; Chen L; Sun J; Zhang L
Front Biosci (Landmark Ed); 2023 Jun; 28(6):115. PubMed ID: 37395016
[TBL] [Abstract][Full Text] [Related]
7. pH- and acoustic-responsive platforms based on perfluoropentane-loaded protein nanoparticles for ovarian tumor-targeted ultrasound imaging and therapy.
Li J; Ji H; Jing Y; Wang S
Nanoscale Res Lett; 2020 Feb; 15(1):31. PubMed ID: 32016619
[TBL] [Abstract][Full Text] [Related]
8. Carboxymethyl-hexanoyl Chitosan Nanodroplets for Ultrasonic Imaging and Drug Delivery to Tumor.
Jinsui Y; Bing S; Muhua L; Yue L; Jianyi L; Meng D; Kuan C; Chaopin Y; Hui Z; Zhiyi C
Curr Pharm Des; 2018; 24(15):1682-1688. PubMed ID: 29766795
[TBL] [Abstract][Full Text] [Related]
9. iRGD Peptide-Mediated Liposomal Nanoparticles with Photoacoustic/Ultrasound Dual-Modality Imaging for Precision Theranostics Against Hepatocellular Carcinoma.
Li H; Shi S; Wu M; Shen W; Ren J; Mei Z; Ran H; Wang Z; Tian Y; Gao J; Zhao H
Int J Nanomedicine; 2021; 16():6455-6475. PubMed ID: 34584411
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional liposome for photoacoustic/ultrasound imaging-guided chemo/photothermal retinoblastoma therapy.
Li M; Bian X; Chen X; Fan N; Zou H; Bao Y; Zhou Y
Drug Deliv; 2022 Dec; 29(1):519-533. PubMed ID: 35156504
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional Nanoparticles for Multimodal Imaging-Guided Low-Intensity Focused Ultrasound/Immunosynergistic Retinoblastoma Therapy.
Wang M; Yang Q; Li M; Zou H; Wang Z; Ran H; Zheng Y; Jian J; Zhou Y; Luo Y; Ran Y; Jiang S; Zhou X
ACS Appl Mater Interfaces; 2020 Feb; 12(5):5642-5657. PubMed ID: 31940169
[TBL] [Abstract][Full Text] [Related]
12. NIR-Light-Triggered Anticancer Strategy for Dual-Modality Imaging-Guided Combination Therapy via a Bioinspired Hybrid PLGA Nanoplatform.
Shen X; Li T; Chen Z; Xie X; Zhang H; Feng Y; Li S; Qin X; Yang H; Wu C; Zheng C; Zhu J; You F; Liu Y
Mol Pharm; 2019 Mar; 16(3):1367-1384. PubMed ID: 30776896
[TBL] [Abstract][Full Text] [Related]
13. Low-intensity focused ultrasound (LIFU)-induced acoustic droplet vaporization in phase-transition perfluoropentane nanodroplets modified by folate for ultrasound molecular imaging.
Liu J; Shang T; Wang F; Cao Y; Hao L; Ren J; Ran H; Wang Z; Li P; Du Z
Int J Nanomedicine; 2017; 12():911-923. PubMed ID: 28184161
[TBL] [Abstract][Full Text] [Related]
14. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
[No Abstract] [Full Text] [Related]
15. Theranostic Nanoplatform with Sequential SDT and ADV Effects in Response to Well-Programmed LIFU Irradiation for Cervical Cancer.
Zhou J; Hou J; Liu S; Xu J; Luo Y; Zheng J; Li X; Wang Z; Ran H; Guo D
Int J Nanomedicine; 2021; 16():7995-8012. PubMed ID: 34916791
[TBL] [Abstract][Full Text] [Related]
16. Low intensity focused ultrasound (LIFU) triggered drug release from cetuximab-conjugated phase-changeable nanoparticles for precision theranostics against anaplastic thyroid carcinoma.
Wang Y; Sui G; Teng D; Wang Q; Qu J; Zhu L; Ran H; Wang Z; Jin C; Wang H
Biomater Sci; 2018 Dec; 7(1):196-210. PubMed ID: 30422139
[TBL] [Abstract][Full Text] [Related]
17. Melanin-loaded biocompatible photosensitive nanoparticles for controlled drug release in combined photothermal-chemotherapy guided by photoacoustic/ultrasound dual-modality imaging.
Wang W; Jing T; Xia X; Tang L; Huang Z; Liu F; Wang Z; Ran H; Li M; Xia J
Biomater Sci; 2019 Oct; 7(10):4060-4074. PubMed ID: 31475710
[TBL] [Abstract][Full Text] [Related]
18. Dual ultrasound-activatable nanodroplets for highly-penetrative and efficient ovarian cancer theranostics.
Yang C; Zhang Y; Luo Y; Qiao B; Wang X; Zhang L; Chen Q; Cao Y; Wang Z; Ran H
J Mater Chem B; 2020 Jan; 8(3):380-390. PubMed ID: 31868193
[TBL] [Abstract][Full Text] [Related]
19. Targeted and pH-facilitated theranostic of orthotopic gastric cancer via phase-transformation doxorubicin-encapsulated nanoparticles enhanced by low-intensity focused ultrasound (LIFU) with reduced side effect.
Liu Z; Ran H; Wang Z; Zhou S; Wang Y
Int J Nanomedicine; 2019; 14():7627-7642. PubMed ID: 31571868
[TBL] [Abstract][Full Text] [Related]
20. Establishment of ultrasound-responsive SonoBacteriaBot for targeted drug delivery and controlled release.
Du M; Wang T; Feng R; Zeng P; Chen Z
Front Bioeng Biotechnol; 2023; 11():1144963. PubMed ID: 36911192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
